Medio Labs is a pathology testing company that uses next-generation gene sequencing to deliver low-cost, fast-turn-around PCR tests for all Coronavirus variants. The company plans to apply these new AI-enhanced diagnostic technologies to a broad range of pathogens, dramatically reduce the cost of pathology testing, and radically expand access to the latest healthcare technologies.